Oncology
11 drugs are in development for Cervical Cancer.
- Companies
- 5
- Clinical trials
- 75
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Cervical Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(9)
| Drug | Company |
|---|---|
| AB308 | Arcus Biosciences, Inc. (RCUS) |
| STRO-004 | SUTRO BIOPHARMA, INC. (STRO) |
| tsc-200-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-201-b0702 | TScan Therapeutics, Inc. (TCRX) |
| tsc-202-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-203-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-a0101 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-a0201 | TScan Therapeutics, Inc. (TCRX) |
| tsc-204-c0702 | TScan Therapeutics, Inc. (TCRX) |
Phase 1/Phase 2(2)
About this indication
Cervical Cancer context
Oncology·MeSH: Uterine Cervical Neoplasms (D002583)
Narrower concept of MeSH descriptor Uterine Cervical Neoplasms
Prevalence
18.0 / 100K
Incidence
7.5 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Cervical Cancer?
BioSniper tracks 11 drugs in development for Cervical Cancer across 5 companies.
How many clinical trials target Cervical Cancer?
There are 75 clinical trials targeting Cervical Cancer tracked by BioSniper.
What is the prevalence of Cervical Cancer?
The estimated prevalence of Cervical Cancer is approximately 18.0 per 100,000 population.